Related Blog Posts
Nothing to see... move along.
Related News
Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
18 hours ago ago from PopEater
CALGARY , Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced the appointment of Dr. Alan Warrander to the role of Senior Vice President, Global Licensing and Business Development. "Dr. Warrander will be responsible for the execution of the global licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson , President and CEO of Oncolytics. "Having reached an ...
Related contentRelated Videos
Nothing to see... move along.
